Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pacemakers Could Aid More Heart Failure Patients

By HospiMedica International staff writers
Posted on 24 Oct 2012
A new study suggests that patients with milder forms of heart failure (HF) can also be treated with a cardiac resynchronization therapy (CRT) device. More...


Researchers at the Karolinska Institutet (Stockholm, Sweden) conducted a study involving 25,171 patients (mean age 74.6 years, 39.9% women) in the Swedish Heart Failure Registry to determine the prevalence of, correlates with, and prognostic impact of QRS prolongation in HF with reduced and preserved ejection fraction (EF). The researchers assessed QRS width and 40 other clinically relevant variables, and the association between QRS width and all-cause mortality was analyzed. Prespecified subgroup analyses by EF were also performed.


The results showed that one-year survival was 77% in QRS over 120 ms, and 82% in QRS under 120 ms; 5-year survival was 42% and 51%, respectively. In all, 31% of the subjects had a QRS time longer than 120 ms. Strong predictors of QRS over 120 ms were higher age, male gender, dilated cardiomyopathy, longer duration of HF, and lower EF. There was no interaction shown between QRS width and EF. The researchers concluded that the study provides a rationale for trials of CRT in HF with preserved EF. The study was published early online on October 5, 2012, in the European Heart Journal.

“This advanced pacemaker has not yet been tried on heart failure caused by a reduced ability of the heart muscles to relax,” said lead author Lars Lund, MD, PhD, and colleagues of the department of medicine. “However, our results indicate that it could be valuable for this type of heart failure too, and this possibility is something that we must now go on to explore.”

A CRT device uses electrical impulses to maintain an adequate heart rate, because either the heart's native pacemaker is not fast enough or there is a block in the heart's electrical conduction system. Modern pacemakers are externally programmable and allow the cardiologist to select the optimum pacing modes for individual patients. Some combine a pacemaker and defibrillator in a single implantable device. Others have multiple electrodes stimulating differing positions within the heart to improve synchronization of the ventricles.

Related Links:

Karolinska Institutet



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.